1. Sectm1a Facilitates Protection against Inflammation-Induced Organ Damage through Promoting TRM Self-Renewal
- Author
-
Xiaohong Wang, Qianqian Li, Kobina Essandoh, Tianqing Peng, Hongkuan Fan, Peng Wang, Guo-Chang Fan, Yutian Li, Xingjiang Mu, Jing Chen, and Karen Domenico
- Subjects
Lipopolysaccharide ,medicine.medical_treatment ,Multiple Organ Failure ,Inflammation ,Monocytes ,03 medical and health sciences ,chemistry.chemical_compound ,Mice ,0302 clinical medicine ,Immune system ,Downregulation and upregulation ,Glucocorticoid-Induced TNFR-Related Protein ,Drug Discovery ,Genetics ,Medicine ,Animals ,Homeostasis ,Molecular Biology ,Tissue homeostasis ,Interleukin 4 ,030304 developmental biology ,Pharmacology ,0303 health sciences ,business.industry ,Macrophages ,Membrane Proteins ,T helper cell ,T-Lymphocytes, Helper-Inducer ,medicine.anatomical_structure ,Cytokine ,chemistry ,030220 oncology & carcinogenesis ,Immunology ,Molecular Medicine ,Original Article ,medicine.symptom ,business ,Immunologic Memory - Abstract
Tissue-resident macrophages (TRMs) are sentinel cells for maintaining tissue homeostasis and organ function. In this study, we discovered that lipopolysaccharide (LPS) administration dramatically reduced TRM populations and suppressed their self-renewal capacities in multiple organs. Using loss- and gain-of-function approaches, we define Sectm1a as a novel regulator of TRM self-renewal. Specifically, at the earlier stage of endotoxemia, Sectm1a deficiency exaggerated acute inflammation-induced reduction of TRM numbers in multiple organs by suppressing their proliferation, which was associated with more infiltrations of inflammatory monocytes/neutrophils and more serious organ damage. By contrast, administration of recombinant Sectm1a enhanced TRM populations and improved animal survival upon endotoxin challenge. Mechanistically, we identified that Sectm1a-induced upregulation in the self-renewal capacity of TRM is dependent on GITR-activated T helper cell expansion and cytokine production. Meanwhile, we found that TRMs may play an important role in protecting local vascular integrity during endotoxemia. Our study demonstrates that Sectm1a contributes to stabling TRM populations through maintaining their self-renewal capacities, which benefits the host immune response to acute inflammation. Therefore, Sectm1a may serve as a new therapeutic agent for the treatment of inflammatory diseases.
- Published
- 2020